Chemical Compound Review:
SureCN6402242 5-[(2R)-2-[[(2S)-2-(3- chlorophenyl)-2...
Synonyms:
LS-34664, AC1O3S63, CL 316243, C20H18ClNO7.2Na
This record was replaced with 5486546.
- Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity. Guerra, C., Koza, R.A., Yamashita, H., Walsh, K., Kozak, L.P. J. Clin. Invest. (1998)
- CL-316,243, a beta3-specific adrenoceptor agonist, enhances insulin-stimulated glucose disposal in nonobese rats. de Souza, C.J., Hirshman, M.F., Horton, E.S. Diabetes (1997)
- Activation of beta(3) adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Mantzoros, C.S., Qu, D., Frederich, R.C., Susulic, V.S., Lowell, B.B., Maratos-Flier, E., Flier, J.S. Diabetes (1996)
- Efficacy of the beta3-adrenergic receptor agonist CL-316243 on experimental bladder hyperreflexia and detrusor instability in the rat. Woods, M., Carson, N., Norton, N.W., Sheldon, J.H., Argentieri, T.M. J. Urol. (2001)
- Effects of beta-adrenergic stimulation on the acutely obstructed ureter in dogs. Murakami, M., Tomiyama, Y., Hayakawa, K., Akahane, M., Ajisawa, Y., Park, Y.C., Ohnishi, N., Sugiyama, T., Kurita, T. J. Pharmacol. Exp. Ther. (2000)
- Targeted gene disruption reveals a leptin-independent role for the mouse beta3-adrenoceptor in the regulation of body composition. Revelli, J.P., Preitner, F., Samec, S., Muniesa, P., Kuehne, F., Boss, O., Vassalli, J.D., Dulloo, A., Seydoux, J., Giacobino, J.P., Huarte, J., Ody, C. J. Clin. Invest. (1997)
- Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans. Weyer, C., Tataranni, P.A., Snitker, S., Danforth, E., Ravussin, E. Diabetes (1998)
- Anti-obesity effect of CL 316,243, a highly specific beta 3-adrenoceptor agonist, in mice with monosodium-L-glutamate-induced obesity. Yoshida, T., Sakane, N., Wakabayashi, Y., Umekawa, T., Kondo, M. Eur. J. Endocrinol. (1994)
- Beta3-adrenergic receptors on white and brown adipocytes mediate beta3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. A study using transgenic and gene knockout mice. Grujic, D., Susulic, V.S., Harper, M.E., Himms-Hagen, J., Cunningham, B.A., Corkey, B.E., Lowell, B.B. J. Biol. Chem. (1997)
- Lipolytic effects of conventional beta 3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative beta 4-adrenoceptor. Galitzky, J., Langin, D., Verwaerde, P., Montastruc, J.L., Lafontan, M., Berlan, M. Br. J. Pharmacol. (1997)
- White adipose tissue contributes to UCP1-independent thermogenesis. Granneman, J.G., Burnazi, M., Zhu, Z., Schwamb, L.A. Am. J. Physiol. Endocrinol. Metab. (2003)
- Effect of tri-iodothyronine on leptin release and leptin mRNA accumulation in rat adipose tissue. Fain, J.N., Bahouth, S.W. Biochem. J. (1998)
- Role of nitric oxide in beta3-adrenoceptor activation on basal tone of internal anal sphincter. Banwait, K.S., Rattan, S. Am. J. Physiol. Gastrointest. Liver Physiol. (2003)
- Hypertrophy of brown adipocytes in brown and white adipose tissues and reversal of diet-induced obesity in rats treated with a beta3-adrenoceptor agonist. Ghorbani, M., Claus, T.H., Himms-Hagen, J. Biochem. Pharmacol. (1997)
- Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines. Dolan, J.A., Muenkel, H.A., Burns, M.G., Pellegrino, S.M., Fraser, C.M., Pietri, F., Strosberg, A.D., Largis, E.E., Dutia, M.D., Bloom, J.D. J. Pharmacol. Exp. Ther. (1994)
- Control of lipolysis in intra-abdominal fat cells of nonhuman primates: comparison with humans. Bousquet-Mélou, A., Galitzky, J., Lafontan, M., Berlan, M. J. Lipid Res. (1995)
- beta3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human beta3-adrenergic receptor. Tavernier, G., Toumaniantz, G., Erfanian, M., Heymann, M.F., Laurent, K., Langin, D., Gauthier, C. Cardiovasc. Res. (2003)
- Effect of adipocyte beta3-adrenergic receptor activation on the type 2 diabetic MKR mice. Kim, H., Pennisi, P.A., Gavrilova, O., Pack, S., Jou, W., Setser-Portas, J., East-Palmer, J., Tang, Y., Manganiello, V.C., Leroith, D. Am. J. Physiol. Endocrinol. Metab. (2006)
- Further evidence for differences between cardiac atypical beta-adrenoceptors and brown adipose tissue beta3-adrenoceptors in the pithed rat. Malinowska, B., Schlicker, E. Br. J. Pharmacol. (1997)
- Indispensable role of mitochondrial UCP1 for antiobesity effect of beta3-adrenergic stimulation. Inokuma, K., Okamatsu-Ogura, Y., Omachi, A., Matsushita, Y., Kimura, K., Yamashita, H., Saito, M. Am. J. Physiol. Endocrinol. Metab. (2006)
- Adiponectin receptor 2 expression in liver and insulin resistance in db/db mice given a beta3-adrenoceptor agonist. Oana, F., Takeda, H., Matsuzawa, A., Akahane, S., Isaji, M., Akahane, M. Eur. J. Pharmacol. (2005)
- Role of the beta(3)-adrenergic receptor and/or a putative beta(4)-adrenergic receptor on the expression of uncoupling proteins and peroxisome proliferator-activated receptor-gamma coactivator-1. Boss, O., Bachman, E., Vidal-Puig, A., Zhang, C.Y., Peroni, O., Lowell, B.B. Biochem. Biophys. Res. Commun. (1999)
- Peroxisome proliferator-activated receptor gamma agonism increases the capacity for sympathetically mediated thermogenesis in lean and ob/ob mice. Sell, H., Berger, J.P., Samson, P., Castriota, G., Lalonde, J., Deshaies, Y., Richard, D. Endocrinology (2004)
- A search for presynaptic beta3-adrenoceptors in the rat. Zelaszczyk, D., Zakrzeska, A., Kwolek, G., Malinowska, B., Schlicker, E. Fundamental & clinical pharmacology. (2005)
- Effect of the beta(3)-adrenergic agonist Cl316,243 on functional differentiation of white and brown adipocytes in primary cell culture. Klaus, S., Seivert, A., Boeuf, S. Biochim. Biophys. Acta (2001)